The Enzyme Alternative
The smarter alternative to Enzyme for medical device teams
Matrix Quality is built by medical device engineers and delivers faster onboarding, richer AI tools, and end-to-end compliance — without Enzyme's complexity or cost.
Matrix Quality vs Enzyme — at a glance
Matrix Quality
Enzyme
Built for Medical Device
Purpose-built for MedTech and Life Sciences
Focused on medical device startups
ISO 13485 Certified
Yes, full certification
Yes, supported
AI-powered features
AI-assisted requirements, risk detection, test generation
No native AI capabilities
Time to value
Days to weeks
Weeks to months depending on configuration
Integrated compliance platform
Requirements, quality, LIMS, eIFU in one platform
eQMS only — no broader platform integration
EU / global support
European team with EU MDR expertise
Primarily US-focused, limited EU presence
This comparison is based on publicly available information and internal analysis as of June 2026. Features and capabilities may change over time. For the most accurate and up-to-date information, you can refer to the official website of Enzyme.
Common frustrations with Enzyme
Teams switching from Enzyme consistently report the same pain points.
Limited scalability as teams growEnzyme is positioned as an eQMS for early-stage medical device startups, and that positioning becomes a liability once teams start to scale. Companies that grow beyond 20–30 users frequently report that workflows become rigid and administrative overhead increases. Organizations approaching Series B or commercial launch often find themselves re-evaluating their QMS stack entirely because Enzyme was not designed for the complexity of a maturing quality management system.
No AI-native capabilitiesIn an industry where AI-assisted document drafting, risk detection, and requirements traceability are rapidly becoming table stakes, Enzyme offers no native AI capabilities. Users looking for AI-assisted CAPA generation, intelligent gap analysis, or automated DHF linking are left doing this work manually. For engineering-driven MedTech teams trying to move fast, the absence of AI tooling is a meaningful competitive disadvantage.
Primarily US-focused with limited EU MDR supportEnzyme's compliance framework is centered on FDA 21 CFR Part 11 and US-market requirements. Companies targeting CE marking under EU MDR 2017/745 or IVDR 2017/746 find that Enzyme provides limited structured support for EU technical file requirements, notified body submissions, and EUDAMED integration. European teams or dual-market companies often need to bolt on additional tooling or manual processes to bridge this gap.
eQMS silo — no integration with upstream engineeringEnzyme operates as a standalone eQMS with no native connection to design controls, requirements management, or software development workflows. This means quality and engineering teams work in separate systems, creating traceability gaps between design inputs, risk files, verification activities, and the quality management system. Maintaining a connected DHF across disconnected tools is time-consuming and audit-risky.
Onboarding and configuration complexityDespite marketing fast onboarding, teams frequently report that configuring Enzyme's document control workflows, approval chains, and form templates to match their specific QMS processes takes longer than expected. Without dedicated implementation support, early-stage teams with lean quality functions can spend weeks getting the system to reflect their SOPs rather than focusing on product development.
Cost structure not transparent for growing teamsEnzyme's pricing model can become unpredictable as headcount grows and more modules are required. Teams that start on a basic plan often encounter stepped pricing as they add users, activate additional compliance modules, or require integrations. For startups managing burn carefully, the total cost of ownership over a 3-year period frequently comes in higher than initially projected.
The challenge
Our solution
When writing, validating, and preparing technical documentation and audits.
During audits thanks to Matrix Quality.
Customers brought their products to market sooner thanks to Matrix Quality.
See exactly how the two platforms stack up on the criteria that matter most to regulated quality teams.
Matrix Quality
Enzyme
This comparison is based on publicly available information and internal analysis as of June 2026. Features and capabilities may change over time. For the most accurate and up-to-date information, you can refer to the official website of Enzyme.
— Industry Fit —
Target industries
Medical Device, Life Sciences
Medical device startups
MedTech-specific workflows
✅ Built-in design controls, DHF, risk management
✅ Document control, CAPA, DHF
Regulatory standards
✅ ISO 13485, IEC 62304, MDR, FDA 21 CFR Part 11
✅ FDA 21 CFR Part 11, ISO 13485
— Compliance —
ISO 13485 certified
✅ Yes
✅ Yes
FDA 21 CFR Part 11
✅ Yes
✅ Yes
Audit trail
✅ Full, immutable audit trail across all modules
✅ Yes, within eQMS
— Usability —
Setup time
✅ Days to weeks
⚠️ Weeks to months
Training required
✅ Minimal — intuitive UI with guided onboarding
⚠️ Moderate — configuration-heavy initial setup
— AI Capabilities —
AI-native
✅ Yes — Matrix Mind embedded across platform
No native AI features
AI features
✅ Requirements analysis, risk detection, test generation, CAPA drafting
Not available
— Support —
EU support
✅ Yes, European team with EU MDR expertise
⚠️ Limited — primarily US-based support
Onboarding support
✅ Dedicated CSM, IQ/OQ included
⚠️ Self-serve with limited dedicated support
Matrix Quality
— Industry Fit —
Target industries
Medical Device, Life Sciences
MedTech-specific workflows
✅ Built-in design controls, DHF, risk management
Regulatory standards
✅ ISO 13485, IEC 62304, MDR, FDA 21 CFR Part 11
— Compliance —
ISO 13485 certified
✅ Yes
FDA 21 CFR Part 11
✅ Yes
Audit trail
✅ Full, immutable audit trail across all modules
— Usability —
Setup time
✅ Days to weeks
Training required
✅ Minimal — intuitive UI with guided onboarding
— AI Capabilities —
AI-native
✅ Yes — Matrix Mind embedded across platform
AI features
✅ Requirements analysis, risk detection, test generation, CAPA drafting
— Support —
EU support
✅ Yes, European team with EU MDR expertise
Onboarding support
✅ Dedicated CSM, IQ/OQ included
Enzyme
— Industry Fit —
Target industries
Medical device startups
MedTech-specific workflows
✅ Document control, CAPA, DHF
Regulatory standards
✅ FDA 21 CFR Part 11, ISO 13485
— Compliance —
ISO 13485 certified
✅ Yes
FDA 21 CFR Part 11
✅ Yes
Audit trail
✅ Yes, within eQMS
— Usability —
Setup time
⚠️ Weeks to months
Training required
⚠️ Moderate — configuration-heavy initial setup
— AI Capabilities —
AI-native
No native AI features
AI features
Not available
— Support —
EU support
⚠️ Limited — primarily US-based support
Onboarding support
⚠️ Self-serve with limited dedicated support
Switching is easy
Migrate from Enzyme in 4 simple steps
We handle the heavy lifting. Most teams are fully live in under 8 weeks.
Free migration assessment (30 min)
We analyse your Enzyme configuration and map it to Matrix Quality.
Automated data export & mapping
Documents, CAPA records, and training data migrated with full traceability and version history preserved.
Configure, validate & sign off
Workflows, roles, and templates configured with IQ/OQ documentation ready.
Go live — and keep improving
Full onboarding with a dedicated Customer Success Manager from day one.
“
“I think we easily saved six months by working with Matrix One to create efficient digital workflows.”
CV
Carl Van Lierde
VP Product Development, Vipun Medical
Book your migration assessment
Free 30-min session
No credit card
No spam, ever
Stop fighting your quality system.
Start shipping safer products.
Join 500+ life sciences companies that chose Matrix Quality. Book a demo with one of our specialists today.